REPLAY HOLDINGS
Summary
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 46 M
Avg. Deal Size£ 46 M
All rights reserved. Copyright © 2025 Datasite
